These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35801613)

  • 1. Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson's Disease.
    Kwan C; Kolivakis T; Huot P
    Can J Neurol Sci; 2023 Sep; 50(5):779-780. PubMed ID: 35801613
    [No Abstract]   [Full Text] [Related]  

  • 2. Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease.
    Espindola M; Rojas NG; Vaisentein G; Da Prat G; Cesarini M; Etcheverry JL; Gatto EM
    Parkinsonism Relat Disord; 2024 Apr; 121():106017. PubMed ID: 38401377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex, drugs and Parkinson's disease.
    Ushe M; Perlmutter JS
    Brain; 2013 Feb; 136(Pt 2):371-3. PubMed ID: 23413258
    [No Abstract]   [Full Text] [Related]  

  • 5. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists.
    Huynh NT; Sid-Otmane L; Panisset M; Huot P
    Can J Neurol Sci; 2016 Nov; 43(6):859-860. PubMed ID: 26842385
    [No Abstract]   [Full Text] [Related]  

  • 11. Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.
    Carbone F; Djamshidian A
    CNS Drugs; 2024 Jun; 38(6):443-457. PubMed ID: 38613665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonist withdrawal syndrome: A comprehensive review.
    Yu XX; Fernandez HH
    J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist withdrawal syndrome in Parkinson disease.
    Rabinak CA; Nirenberg MJ
    Arch Neurol; 2010 Jan; 67(1):58-63. PubMed ID: 20065130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced impulse control disorders: a review.
    Atmaca M
    Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE; Thompson PD; Kiley MA
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
    Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE
    Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lethargy after abrupt apomorphine withdrawal in Parkinson's disease.
    Cavallieri F; Fraix V; Meoni S; Krack P; Moro E; Castrioto A
    J Neurol Sci; 2019 Sep; 404():44-46. PubMed ID: 31325667
    [No Abstract]   [Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
    Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
    J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.